From: Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma
Transfectant | SF IC50 for EV/HAS3 transfectants | ||
---|---|---|---|
0Â mM MU | 0.1Â mM MU | 0.2Â mM MU | |
786-O EV | 8.586 | 4.405 | 1.201 |
786-O HAS3 | 9.736 | 7.897 | 7.254 |
Caki-1 EV | 8.216 | 5.544 | 2.912 |
Caki-1 HAS3 | 9.043 | 9.194 | 7.266 |
SF IC50 for shRNA transfectants | |||
---|---|---|---|
 | Ctrl | HAS3 # 1 | HAS3 # 2 |
786-O | 8.386 | 1.974 | 3.049 |
Caki-1 | 7.385 | 3.120 | 2.792 |